Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas

Aleksandra Grzanka; Dariusz Grzanka; Maciej Gagat; Tadeusz Tadrowski; Małgorzata Sokołowska-Wojdyło; Andrzej Marszałek; Waldemar Placek

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2012
vol. 63

Send email

Copy url:

abstract:

Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas

Aleksandra Grzanka

,

Dariusz Grzanka

,

Maciej Gagat

,

Tadeusz Tadrowski

,

Małgorzata Sokołowska-Wojdyło

,

Andrzej Marszałek

,

Waldemar Placek

POL J PATHOL 2012; 2: 101-105

Online publish date: 2012/08/03

View full text Get citation

Cutaneous T-cell lymphomas (CTCLs) are slowly progressive diseases with a poor prognosis. There are no specific prognostic factors in development of cutaneous lymphomas. SATB1 protein controls expression of many genes, including the cellular cycle and apoptosis. The subject of our study was the expression of SATB1 protein in the skin sample in patients with mycosis fungoides and Sezary syndrome and its correlation with clinical course. Immunohistochemical reaction with SATB1 antibody was observed in 29 cases of mycosis fungoides of different stages (15 patients) and two cases of Sezary syndrome. SATB1 expression was observed in 22 cases of mycosis fungoides, 7 of which were in the patch stage, 11 were in the plaque stage and 4 were in the tumor stage. SATB1 expression was not found in 2 cases of the patch stage, 4 cases of the plaque stage and one case of the tumor stage. Negative reaction was confirmed in both cases of the Sezary syndrome. There were no changes in SATB1 expression during progression of the disease. A group of patients with the positive reaction of the SATB1 is characterized by a noticeably longer time to progression between the stages. The SATB1 expression seems to be a potential prognosis factor confirming the inner heterogeneous features of CTCLs.

keywords:

Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas

Aleksandra Grzanka , Dariusz Grzanka , Maciej Gagat , Tadeusz Tadrowski , Małgorzata Sokołowska-Wojdyło , Andrzej Marszałek , Waldemar Placek

cutaneous T-cell lymphoma, CTCL, SATB1, prognostic marker, mycosis fungoides

Aleksandra Grzanka

,

Dariusz Grzanka

,

Maciej Gagat

,

Tadeusz Tadrowski

,

Małgorzata Sokołowska-Wojdyło

,

Andrzej Marszałek

,

Waldemar Placek